Novo Nordisk A/S, Prologis, and BlackRock are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose earnings and revenues are expected to grow at above-average rates compared to their industry or the broader market. These firms typically reinvest profits back into the business rather than paying out dividends, so investors buy them primarily for capital appreciation. While they offer high return potential, growth stocks often carry greater volatility and valuation risk. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Shares of NYSE:NVO traded down $1.15 during midday trading on Wednesday, reaching $64.25. The company had a trading volume of 6,237,816 shares, compared to its average volume of 6,448,018. The stock has a market cap of $288.32 billion, a PE ratio of 19.53, a P/E/G ratio of 0.90 and a beta of 0.65. The company has a quick ratio of 0.55, a current ratio of 0.74 and a debt-to-equity ratio of 0.62. Novo Nordisk A/S has a 1-year low of $57.00 and a 1-year high of $148.15. The business's 50 day moving average price is $68.30 and its 200 day moving average price is $85.37.
Read Our Latest Research Report on NVO
Prologis (PLD)
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.
Prologis stock traded down $2.22 during trading hours on Wednesday, hitting $107.48. The company had a trading volume of 2,468,517 shares, compared to its average volume of 4,184,625. Prologis has a one year low of $85.35 and a one year high of $132.57. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.75 and a quick ratio of 0.43. The firm has a market cap of $99.73 billion, a PE ratio of 26.87, a PEG ratio of 2.70 and a beta of 1.25. The firm has a 50-day moving average of $105.46 and a 200 day moving average of $111.24.
Read Our Latest Research Report on PLD
BlackRock (BLK)
BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
NYSE:BLK traded up $6.82 during trading hours on Wednesday, reaching $966.00. 225,751 shares of the company were exchanged, compared to its average volume of 685,604. The company has a market capitalization of $149.97 billion, a P/E ratio of 23.00, a P/E/G ratio of 1.90 and a beta of 1.41. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.23 and a quick ratio of 5.23. BlackRock has a 1-year low of $752.30 and a 1-year high of $1,084.22. The business has a 50 day moving average of $912.82 and a 200 day moving average of $978.16.
Read Our Latest Research Report on BLK
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Novo Nordisk A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.
While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.